Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and strokes.

Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver, Cana ...